Exact Mass: 789.6485299999999
Exact Mass Matches: 789.6485299999999
Found 477 metabolites which its exact mass value is equals to given mass value 789.6485299999999,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Sulfobromophthalein
V - Various > V04 - Diagnostic agents > V04C - Other diagnostic agents > V04CE - Tests for liver functional capacity D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D010635 - Phenolphthaleins D004396 - Coloring Agents Same as: D08548
PC(14:0/22:0)
PC(14:0/22:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:0/22:0), in particular, consists of one chain of myristic acid at the C-1 position and one chain of behenic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(14:0/22:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:0/22:0), in particular, consists of one chain of myristic acid at the C-1 position and one chain of behenic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.
PC(16:0/20:0)
PC(16:0/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/20:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(16:0/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/20:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.
PC(18:0/18:0)
PC(18:0/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/18:0), in particular, consists of two chains of stearic acid at the C-1 and C-2 positions. The stearic acid moieties are derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(18:0/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/18:0), in particular, consists of two chains of stearic acid at the C-1 and C-2 positions. The stearic acid moieties are derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.
PC(20:0/16:0)
PC(20:0/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:0/16:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(20:0/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:0/16:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.
PC(22:0/14:0)
PC(22:0/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:0/14:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of myristic acid at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(22:0/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:0/14:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of myristic acid at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.
PE(15:0/24:0)
PE(15:0/24:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(15:0/24:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the lignoceric acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(15:0/24:0) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(15:0/24:0), in particular, consists of one pentadecanoyl chain to the C-1 atom, and one tetracosanoyl to the C-2 atom. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.
PE(24:0/15:0)
PE(24:0/15:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(24:0/15:0), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The lignoceric acid moiety is derived from groundnut oil, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(24:0/15:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(24:0/15:0), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The lignoceric acid moiety is derived from groundnut oil, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.
PE-NMe(14:0/24:0)
PE-NMe(14:0/24:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(14:0/24:0), in particular, consists of one chain of myristic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.
PE-NMe(16:0/22:0)
PE-NMe(16:0/22:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(16:0/22:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of behenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.
PE-NMe(18:0/20:0)
PE-NMe(18:0/20:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:0/20:0), in particular, consists of one chain of stearic acid at the C-1 position and one chain of arachidic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.
PE-NMe(20:0/18:0)
PE-NMe(20:0/18:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(20:0/18:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of stearic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.
PE-NMe(22:0/16:0)
PE-NMe(22:0/16:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(22:0/16:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of palmitic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.
PE-NMe(24:0/14:0)
PE-NMe(24:0/14:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(24:0/14:0), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of myristic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.
PE-NMe2(15:0/22:0)
PE-NMe2(15:0/22:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(15:0/22:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of behenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.
PE-NMe2(22:0/15:0)
PE-NMe2(22:0/15:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(22:0/15:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.
1,2-Distearoyllecithin
1,2-Distearoyl-sn-glycero-3-phosphocholine
A phosphatidylcholine 36:0 in which both phosphatidyl acyl groups are specified as stearoyl (octadecanoyl).
PC(13:0/23:0)
PC(15:0/21:0)
PC(16:0/20:0)[U]
PC(17:0/19:0)[U]
PC(18:0/18:0)[S]
PC(19:0/17:0)[U]
PC(21:0/15:0)[U]
PC(23:0/13:0)[U]
PC(24:0/12:0)[U]
PC(25:0/11:0)[U]
PC(O-16:0/21:0)[U]
C45H92NO7P (789.6611051999998)
PC(O-17:0/20:0)
C45H92NO7P (789.6611051999998)
PE(18:0/21:0)[U]
PE(19:0/20:0)[U]
PE(O-18:0/22:0)[U]
C45H92NO7P (789.6611051999998)
PE(O-18:0/22:0)
C45H92NO7P (789.6611051999998)
PE O-40:0
C45H92NO7P (789.6611051999998)
HexCer 38:0;O4
1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE DIHYDRATE
(2-Docosanoyloxy-3-tetradecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
2-[[(2S,3R)-2-(docosanoylamino)-3-hydroxyoctadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[[(E,2S,3R)-2-[[(Z,9S,10S)-9,10-dihydroxyoctadec-12-enoyl]amino]-3-hydroxyicos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C43H86N2O8P+ (789.6121466000001)
N-(2-hydroxyhenicosanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(2-hydroxydocosanoylamino)-15-methylhexadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
C44H90N2O7P+ (789.6485299999999)
2-[[(2S,3R)-2-(hexacosanoylamino)-3-hydroxytetradecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] tetracontanoate
C45H92NO7P (789.6611051999998)
(3-Nonoxy-2-octacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C45H92NO7P (789.6611051999998)
2-[3-nonanoyloxy-2-[(16Z,19Z,22Z,25Z)-octacosa-16,19,22,25-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[3-[(Z)-nonadec-9-enoyl]oxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[3-heptadecanoyloxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[3-nonadecanoyloxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[2-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]oxy-3-undecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[2-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[3-henicosanoyloxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxy-3-tridecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-pentadecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[3-[(Z)-henicos-11-enoyl]oxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[3-[(Z)-heptadec-9-enoyl]oxy-2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
(2-Nonanoyloxy-3-octacosoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C45H92NO7P (789.6611051999998)
(2-Heptadecanoyloxy-3-icosoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C45H92NO7P (789.6611051999998)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-icosoxypropan-2-yl] icosanoate
C45H92NO7P (789.6611051999998)
2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxydocosane-1-sulfonic acid
C48H87NO5S (789.6304611999999)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] heptacosanoate
C45H92NO7P (789.6611051999998)
(4E,8E,12E)-3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]tetracosa-4,8,12-triene-1-sulfonic acid
C48H87NO5S (789.6304611999999)
2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxyhexacosane-1-sulfonic acid
C48H87NO5S (789.6304611999999)
(4E,8E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]tetracosa-4,8-diene-1-sulfonic acid
C48H87NO5S (789.6304611999999)
(E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]tetracos-4-ene-1-sulfonic acid
C48H87NO5S (789.6304611999999)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentacosoxypropan-2-yl] pentadecanoate
C45H92NO7P (789.6611051999998)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tricosoxypropan-2-yl] heptadecanoate
C45H92NO7P (789.6611051999998)
(4E,8E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxydocosa-4,8-diene-1-sulfonic acid
C48H87NO5S (789.6304611999999)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] pentacosanoate
C45H92NO7P (789.6611051999998)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] octacosanoate
C45H92NO7P (789.6611051999998)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexacosoxypropan-2-yl] tetradecanoate
C45H92NO7P (789.6611051999998)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-henicosoxypropan-2-yl] nonadecanoate
C45H92NO7P (789.6611051999998)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tetracosoxypropan-2-yl] hexadecanoate
C45H92NO7P (789.6611051999998)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecoxypropan-2-yl] henicosanoate
C45H92NO7P (789.6611051999998)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptacosoxypropan-2-yl] tridecanoate
C45H92NO7P (789.6611051999998)
(E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxydocos-4-ene-1-sulfonic acid
C48H87NO5S (789.6304611999999)
3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]tetracosane-1-sulfonic acid
C48H87NO5S (789.6304611999999)
(4E,8E,12E)-2-[[(15Z,18Z)-hexacosa-15,18-dienoyl]amino]-3-hydroxydocosa-4,8,12-triene-1-sulfonic acid
C48H87NO5S (789.6304611999999)
(E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxyhexacos-4-ene-1-sulfonic acid
C48H87NO5S (789.6304611999999)
(4E,8E)-2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxyhexacosa-4,8-diene-1-sulfonic acid
C48H87NO5S (789.6304611999999)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecoxypropan-2-yl] tricosanoate
C45H92NO7P (789.6611051999998)
(4E,8E,12E)-2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxyhexacosa-4,8,12-triene-1-sulfonic acid
C48H87NO5S (789.6304611999999)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-docosoxypropan-2-yl] octadecanoate
C45H92NO7P (789.6611051999998)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octacosoxypropan-2-yl] dodecanoate
C45H92NO7P (789.6611051999998)
(3-Henicosoxy-2-hexadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C45H92NO7P (789.6611051999998)
(3-Tetracosoxy-2-tridecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C45H92NO7P (789.6611051999998)
(2-Tetradecanoyloxy-3-tricosoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C45H92NO7P (789.6611051999998)
(3-Heptadecoxy-2-icosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C45H92NO7P (789.6611051999998)
(2-Tetracosanoyloxy-3-tridecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C45H92NO7P (789.6611051999998)
(3-Decoxy-2-heptacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C45H92NO7P (789.6611051999998)
(2-Dodecanoyloxy-3-pentacosoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C45H92NO7P (789.6611051999998)
(3-Nonadecoxy-2-octadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C45H92NO7P (789.6611051999998)
(3-Docosoxy-2-pentadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C45H92NO7P (789.6611051999998)
(2-Decanoyloxy-3-heptacosoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C45H92NO7P (789.6611051999998)
(2-Hexacosanoyloxy-3-undecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C45H92NO7P (789.6611051999998)
(2-Docosanoyloxy-3-pentadecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C45H92NO7P (789.6611051999998)
(3-Dodecoxy-2-pentacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C45H92NO7P (789.6611051999998)
(3-Hexacosoxy-2-undecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C45H92NO7P (789.6611051999998)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] triacontanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] nonacosanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] octacosanoate
4-[3-docosanoyloxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-[(Z)-heptadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxy-3-octadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-[(Z)-hexadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-icosanoyloxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(Z)-henicos-11-enoyl]oxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-[(Z)-octadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-hexadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(Z)-icos-11-enoyl]oxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(Z)-docos-13-enoyl]oxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-[(Z)-nonadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
[2-(12-hydroxyoctadecanoyloxy)-3-[(Z)-octadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecoxypropan-2-yl] docosanoate
C45H92NO7P (789.6611051999998)
(2-Henicosanoyloxy-3-hexadecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C45H92NO7P (789.6611051999998)
(2-Nonadecanoyloxy-3-octadecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C45H92NO7P (789.6611051999998)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] tetracosanoate
C45H92NO7P (789.6611051999998)
(3-Tetradecoxy-2-tricosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C45H92NO7P (789.6611051999998)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] hexacosanoate
C45H92NO7P (789.6611051999998)
(2-Octacosanoyloxy-3-octanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] hentriacontanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecanoyloxypropan-2-yl] henicosanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecanoyloxypropan-2-yl] icosanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] docosanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] tricosanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] tetracosanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] hexacosanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] pentacosanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] heptacosanoate
(3-Decanoyloxy-2-hexacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
(3-Dodecanoyloxy-2-tetracosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
(3-Heptadecanoyloxy-2-nonadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
(4Z,7Z)-N-[(4E,8E,12E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentacosa-4,8,12-trien-2-yl]hexadeca-4,7-dienamide
(18Z,21Z)-N-[(4E,8E,12E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptadeca-4,8,12-trien-2-yl]tetracosa-18,21-dienamide
(2-Heptacosanoyloxy-3-nonanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
(14Z,16Z)-N-[(4E,8E,12E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxynonadeca-4,8,12-trien-2-yl]docosa-14,16-dienamide
(2-Tricosanoyloxy-3-tridecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
[2-[(E)-10-hydroxyoctadec-12-enoyl]oxy-3-octadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
(2-Pentacosanoyloxy-3-undecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
(11Z,14Z)-N-[(4E,8E,12E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadeca-4,8,12-trien-2-yl]hexacosa-11,14-dienamide
(2-Henicosanoyloxy-3-pentadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
(10Z,12Z)-N-[(4E,8E,12E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytricosa-4,8,12-trien-2-yl]octadeca-10,12-dienamide
2-[[2-(Docosanoylamino)-3-hydroxyoctadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[[2-(Hexacosanoylamino)-3-hydroxytetradecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[Hydroxy-[3-hydroxy-2-(pentacosanoylamino)pentadecoxy]phosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[Hydroxy-[3-hydroxy-2-(tetracosanoylamino)hexadecoxy]phosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[Hydroxy-[3-hydroxy-2-(tricosanoylamino)heptadecoxy]phosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[[2-(Henicosanoylamino)-3-hydroxynonadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[Hydroxy-[3-hydroxy-2-(icosanoylamino)icosoxy]phosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[Hydroxy-[3-hydroxy-2-(nonadecanoylamino)henicosoxy]phosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[Hydroxy-[3-hydroxy-2-(octadecanoylamino)docosoxy]phosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] tricosanoate
[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] hexacosanoate
4-[3-tetracosanoyloxy-2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
[(2R)-3-pentacosanoyloxy-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
4-[2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxy-3-tricosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
(5E,8E,11E,14E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptadec-4-en-2-yl]tetracosa-5,8,11,14-tetraenamide
4-[2-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-3-heptadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-tetracosanoyloxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-docosanoyloxy-3-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxy-2-octadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-3-hexadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(7E,9E)-nonadeca-7,9-dienoyl]oxy-2-[(E)-nonadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(18E,21E)-tetracosa-18,21-dienoyl]oxy-3-[(E)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-pentadecanoyloxy-3-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-icosanoyloxy-3-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(11E,14E)-icosa-11,14-dienoyl]oxy-2-[(E)-octadec-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] docosanoate
4-[2-[(E)-henicos-9-enoyl]oxy-3-[(11E,14E)-heptadeca-11,14-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
2-[[(2R,3S)-2-(docosanoylamino)-3-hydroxyoctadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
[(2S)-3-henicosanoyloxy-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-pentadecanoyloxypropyl] tetracosanoate
4-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-hexacosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(11E,14E)-pentacosa-11,14-dienoyl]oxy-2-[(E)-tridec-8-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(15E,18E,21E)-tetracosa-15,18,21-trienoyl]oxy-2-tetradecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(9E,11E)-henicosa-9,11-dienoyl]oxy-2-[(E)-heptadec-7-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(E)-docos-11-enoyl]oxy-3-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-henicosanoyloxy-3-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
2-[hydroxy-[(2S,3R)-3-hydroxy-2-(octadecanoylamino)docosoxy]phosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
4-[3-[(E)-tetracos-11-enoyl]oxy-2-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxy-2-tridecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
[(2S)-3-docosanoyloxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] hexacosanoate
4-[2-[(E)-pentadec-9-enoyl]oxy-3-[(14E,16E)-tricosa-14,16-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(E)-icos-11-enoyl]oxy-2-[(10E,12E)-octadeca-10,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-nonadecanoyloxy-3-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
2-[hydroxy-[(2S,3R)-3-hydroxy-2-(pentacosanoylamino)pentadecoxy]phosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hexadecanoyloxypropyl] tricosanoate
4-[3-[(E)-pentadec-9-enoyl]oxy-2-[(14E,16E)-tricosa-14,16-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
2-[hydroxy-[(2S,3R)-3-hydroxy-2-(icosanoylamino)icosoxy]phosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
[(2R)-3-tricosanoyloxy-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] pentacosanoate
4-[2-[(E)-icos-11-enoyl]oxy-3-[(10E,12E)-octadeca-10,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(E)-hexacos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-dodecanoyloxy-3-[(17E,20E,23E)-hexacosa-17,20,23-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(15E,18E,21E)-tetracosa-15,18,21-trienoyl]oxy-3-tetradecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
2-[hydroxy-[(2S,3R)-3-hydroxy-2-(tricosanoylamino)heptadecoxy]phosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
4-[3-nonadecanoyloxy-2-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-dodecanoyloxy-2-[(17E,20E,23E)-hexacosa-17,20,23-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(9E,11E)-henicosa-9,11-dienoyl]oxy-3-[(E)-heptadec-7-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(E)-henicos-9-enoyl]oxy-2-[(11E,14E)-heptadeca-11,14-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(7E,9E)-nonadeca-7,9-dienoyl]oxy-3-[(E)-nonadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
(5E,8E,11E,14E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptadec-8-en-2-yl]tetracosa-5,8,11,14-tetraenamide
4-[2-[(14E,16E)-docosa-14,16-dienoyl]oxy-3-[(E)-hexadec-7-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-icosanoyloxy-2-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
[(2R)-3-decanoyloxy-2-hexacosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
4-[3-docosanoyloxy-2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-pentadecanoyloxy-2-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(18E,21E)-tetracosa-18,21-dienoyl]oxy-2-[(E)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(11E,14E)-pentacosa-11,14-dienoyl]oxy-3-[(E)-tridec-8-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-2-heptadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
[(2S)-2-decanoyloxy-3-hexacosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
4-[2-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-[(E)-hexacos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(14E,16E)-docosa-14,16-dienoyl]oxy-2-[(E)-hexadec-7-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxy-3-octadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-hexacosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
[(2S)-2-dodecanoyloxy-3-tetracosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
4-[2-[(E)-dodec-5-enoyl]oxy-3-[(11E,14E)-hexacosa-11,14-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
2-[hydroxy-[(2S,3R)-3-hydroxy-2-(nonadecanoylamino)henicosoxy]phosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
4-[3-[(E)-docos-11-enoyl]oxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tetradecanoyloxypropyl] pentacosanoate
4-[3-henicosanoyloxy-2-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-2-hexadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(11E,14E)-icosa-11,14-dienoyl]oxy-3-[(E)-octadec-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxy-3-tridecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(9E,12E)-pentadeca-9,12-dienoyl]oxy-3-[(E)-tricos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(E)-tetracos-11-enoyl]oxy-3-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(9E,12E)-pentadeca-9,12-dienoyl]oxy-2-[(E)-tricos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
2-[[(2S,3R)-2-(henicosanoylamino)-3-hydroxynonadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
4-[3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxy-2-tricosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
2-[hydroxy-[(2S,3R)-3-hydroxy-2-(tetracosanoylamino)hexadecoxy]phosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
4-[3-[(E)-dodec-5-enoyl]oxy-2-[(11E,14E)-hexacosa-11,14-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
2-[[2-(Dodecanoylamino)-3-hydroxyoctacosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[Hydroxy-[3-hydroxy-2-(pentadecanoylamino)pentacosoxy]phosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[[2-(Heptadecanoylamino)-3-hydroxytricosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[Hydroxy-[3-hydroxy-2-(tetradecanoylamino)hexacosoxy]phosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[[2-(Hexadecanoylamino)-3-hydroxytetracosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[Hydroxy-[3-hydroxy-2-(tridecanoylamino)heptacosoxy]phosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[[2-[[(Z)-henicos-11-enoyl]amino]-3,4-dihydroxyoctadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C44H90N2O7P+ (789.6485299999999)
2-[Hydroxy-[3-hydroxy-2-(triacontanoylamino)decoxy]phosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[[2-(Butanoylamino)-3-hydroxyhexatriacontoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[Hydroxy-[3-hydroxy-2-(nonacosanoylamino)undecoxy]phosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[Hydroxy-[3-hydroxy-2-(pentanoylamino)pentatriacontoxy]phosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[Hydroxy-[3-hydroxy-2-(propanoylamino)heptatriacontoxy]phosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[Hydroxy-[3-hydroxy-2-(undecanoylamino)nonacosoxy]phosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[(2-Acetamido-3-hydroxyoctatriacontoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[Hydroxy-[3-hydroxy-2-(nonanoylamino)hentriacontoxy]phosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[[2-(Heptacosanoylamino)-3-hydroxytridecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[Hydroxy-[3-hydroxy-2-(octanoylamino)dotriacontoxy]phosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[[2-(Hentriacontanoylamino)-3-hydroxynonoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[Hydroxy-[3-hydroxy-2-(octacosanoylamino)dodecoxy]phosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[[2-(Heptanoylamino)-3-hydroxytritriacontoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[[2-(Dotriacontanoylamino)-3-hydroxyoctoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[[2-(Decanoylamino)-3-hydroxytriacontoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[[2-(Hexanoylamino)-3-hydroxytetratriacontoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C45H94N2O6P+ (789.6849133999999)
2-[[(E)-2-(henicosanoylamino)-3,4-dihydroxyoctadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C44H90N2O7P+ (789.6485299999999)
1-tetradecanoyl-2-docosanoyl-sn-glycero-3-phosphocholine
A phosphatidylcholine 36:0 in which the acyl groups at positions 1 and 2 are tetradecanoyl and docosanoyl respectively.
1-docosanoyl-2-tetradecanoyl-sn-glycero-3-phosphocholine
A phosphatidylcholine 36:0 in which the acyl groups specified at positions 1 and 2 are docosanoyl and tetradecanoyl respectively.
1-palmitoyl-2-icosanoyl-sn-glycero-3-phosphocholine
A 1,2-diacyl-sn-glycero-3-phosphocholine where the acyl groups at positions 1 and 2 are palmitoyl and icosanoyl respectively.
1-eicosanoyl-2-hexadecanoyl-sn-glycero-3-phosphocholine
A phosphatidylcholine 36:0 in which the acyl groups specified at positions 1 and 2 are eicosanoyl and hexadecanoyl respectively.
phosphatidylcholine 36:0
A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 36 carbons in total and 0 double bonds.
1-icosanoyl-2-palmitoyl-sn-glycero-3-phosphocholine
A phosphatidylcholine 36:0 where the acyl substituents at positions 1 and 2 are icosanoyl and palmitoyl respectively.
MePC(35:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
CerP(47:6)
C47H84NO6P (789.6035933999999)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
MePC(36:0)
C45H92NO7P (789.6611051999998)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
Hex1Cer(38:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
Hex1Cer(41:5)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved